Early Oral Anticoagulation Monotherapy After PCI: Insights from the POEM Trial
{{output}}
Background: In high-bleeding-risk (HBR) patients undergoing percutaneous coronary intervention (PCI), shortening dual antiplatelet therapy (DAPT) is essential, but the optimal approach in those requiring oral anticoagulation (OAC... ...
